The Repurposing Drugs in Oncology (ReDO) Project

The Repurposing Drugs in Oncology (ReDO) Project seeks to repurpose well-known and well-characterised non-cancer drugs for new uses in oncology. The rationale for this project is presented, examining current issues in oncological drug development, challenges for health systems, and existing and futu...

Full description

Saved in:
Bibliographic Details
Published inEcancermedicalscience Vol. 8; p. 442
Main Authors Pantziarka, Pan, Bouche, Gauthier, Meheus, Lydie, Sukhatme, Vidula, Sukhatme, Vikas P, Vikas, P
Format Journal Article
LanguageEnglish
Published England Cancer Intelligence 01.01.2014
Subjects
Policy
drug development
drug repurposing
health policy
metronomics
ReDO Project
health economics
Online AccessGet full text
ISSN1754-6605
1754-6605
DOI10.3332/ecancer.2014.442

Cover

More Information
Summary:The Repurposing Drugs in Oncology (ReDO) Project seeks to repurpose well-known and well-characterised non-cancer drugs for new uses in oncology. The rationale for this project is presented, examining current issues in oncological drug development, challenges for health systems, and existing and future patient needs. In addition to discussing the advantages of repurposing, the paper also outlines some of the characteristics used in the selection of drug candidates by this project. Challenges in moving candidate drugs into clinical trial and subsequent practice are also discussed.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1754-6605
1754-6605
DOI:10.3332/ecancer.2014.442